PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFluphenazine
Fluphenazine
Fluphenazine (fluphenazine) is a small molecule pharmaceutical. Fluphenazine was first approved as Prolixin decanoate on 1982-01-01. It is used to treat psychotic disorders and schizophrenia in the USA. The pharmaceutical is active against D(2) dopamine receptor. In addition, it is known to target D(1A) dopamine receptor, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 7, D(1B) dopamine receptor, 5-hydroxytryptamine receptor 6, and histamine H1 receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
mental disordersD001523
Trade Name
FDA
EMA
Fluphenazine (discontinued: Fluphenazine, Permitil, Prolixin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Fluphenazine hydrochloride
Tradename
Company
Number
Date
Products
PROLIXINBristol Myers SquibbN-012145 DISCN1982-01-01
1 products, RLD
PROLIXINBristol Myers SquibbN-011751 DISCN1982-01-01
5 products
PERMITILMerck & CoN-016008 DISCN1982-01-01
1 products
PERMITILMerck & CoN-012419 DISCN1982-01-01
1 products
PERMITILMerck & CoN-012034 DISCN1982-01-01
4 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
fluphenazine decanoateANDA2025-11-07
fluphenazine hydrochlorideANDA2026-01-29
fluphenazine hydrochorideANDA2025-10-08
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N05: Psycholeptics
— N05A: Antipsychotics
— N05AB: Phenothiazines with piperazine structure, antipsychotics
— N05AB02: Fluphenazine
HCPCS
Code
Description
J2680
Injection, fluphenazine decanoate, up to 25 mg
Clinical
Clinical Trials
18 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
VomitingD014839—R11.1——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFluphenazine
INNfluphenazine
Description
Fluphenazine is a member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position. It has a role as a phenothiazine antipsychotic drug, a dopaminergic antagonist and an anticoronaviral agent. It is an organofluorine compound, a member of phenothiazines and a N-alkylpiperazine. It derives from a hydride of a 10H-phenothiazine.
Classification
Small molecule
Drug classTypical antipsychotic
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
Identifiers
PDB—
CAS-ID69-23-8
RxCUI—
ChEMBL IDCHEMBL726
ChEBI ID5123
PubChem CID3372
DrugBankDB00623
UNII IDS79426A41Z (ChemIDplus, GSRS)
Target
Agency Approved
DRD2
DRD2
Organism
Homo sapiens
Gene name
DRD2
Gene synonyms
NCBI Gene ID
Protein name
D(2) dopamine receptor
Protein synonyms
Dopamine D2 receptor, seven transmembrane helix receptor
Uniprot ID
Mouse ortholog
Drd2 (13489)
D(2) dopamine receptor (Q0VGH9)
Alternate
DRD1
DRD1
HTR2A
HTR2A
HTR7
HTR7
DRD5
DRD5
HTR6
HTR6
HRH1
HRH1
Organism
Homo sapiens
Gene name
DRD1
Gene synonyms
NCBI Gene ID
Protein name
D(1A) dopamine receptor
Protein synonyms
Dopamine D1 receptor
Uniprot ID
Mouse ortholog
Drd1 (13488)
D(1A) dopamine receptor (Q8C8P8)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Fluphenazine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,673 documents
View more details
Safety
Black-box Warning
Black-box warning for: Fluphenazine decanoate, Fluphenazine hydrochloride, Fluphenazine hydrochoride
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,512 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use